Literature DB >> 28566952

Prevalence of Multiple Sclerosis in the Middle Black Sea Region of Turkey and Demographic Characteristics of Patients.

Neslihan Akdemir1, Murat Terzi1, Nilden Arslan2, Musa Onar1.   

Abstract

INTRODUCTION: Multiple sclerosis (MS), a demyelinating disease of the central nervous system, is increasing in prevalence worldwide. Other than small-scale studies, there is a scarcity of data on the prevalence of MS in Turkey. The present study aimed to elucidate the prevalence of MS in the Middle Black Sea Region and the demographic characteristics of patients.
METHODS: Patients living in the Middle Black Sea Region and who were diagnosed with MS were included. The study was designed based hospital of Turkey.
RESULTS: A total of 1,787 patients were interviewed, and a diagnosis of MS was confirmed in 1,584. The prevalence of MS was found to be 43.2/100,000 in the Middle Black Sea Region; this was calculated based on the total population and number of patients in the provinces and districts in this region. The mean age at the disease onset was 29.39±7.6 years. Among the patients, 1,299 (81.9%) had relapsing-remitting MS, 74 had secondary progressive MS, 77 had relapsing-progressive MS, 47 had primary progressive MS, and 87 had clinically isolated syndrome.
CONCLUSION: The Middle Black Sea Region was found to have a high risk for the prevalence of MS. This study is the most comprehensive epidemiologic study having the largest geographical distribution on the prevalence of MS in Turkey.

Entities:  

Keywords:  Middle Black Sea Region; epidemiology; multiple sclerosis; prevalence

Year:  2017        PMID: 28566952      PMCID: PMC5439464          DOI: 10.5152/npa.2016.12451

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  29 in total

Review 1.  A systematic review of several potential non-genetic risk factors for multiple sclerosis.

Authors:  H Coo; K J Aronson
Journal:  Neuroepidemiology       Date:  2004 Jan-Apr       Impact factor: 3.282

2.  Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.

Authors:  Mohammad Ali Sahraian; Saeideh Khorramnia; Mina Mohammad Ebrahim; Zahra Moinfar; Jamshid Lotfi; Hossien Pakdaman
Journal:  Eur Neurol       Date:  2010-11-13       Impact factor: 1.710

3.  Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?

Authors:  Adnan Al-Araji; Ayad I Mohammed
Journal:  J Neurol Sci       Date:  2005-07-15       Impact factor: 3.181

4.  Clustering of autoimmune disease in families at high risk for multiple sclerosis?

Authors:  Sreeram V Ramagopalan; David A Dyment; Blanca M Herrera; Maria Criscuoli; Irene M Yee; A Dessa Sadovnick; George C Ebers
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

5.  Increasing prevalence and incidence of multiple sclerosis in northern Japan.

Authors:  H Houzen; M Niino; D Hata; F Nakano; S Kikuchi; T Fukazawa; H Sasaki
Journal:  Mult Scler       Date:  2008-06-23       Impact factor: 6.312

6.  Prevalence of multiple sclerosis in Denmark 1950--2005.

Authors:  Joan Bentzen; Esben Meulengracht Flachs; Egon Stenager; Henrik Brønnum-Hansen; Nils Koch-Henriksen
Journal:  Mult Scler       Date:  2010-03-09       Impact factor: 6.312

7.  Familial recurrence risks for multiple sclerosis in Australia.

Authors:  C O'Gorman; S Freeman; B V Taylor; H Butzkueven; S A Broadley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-05-07       Impact factor: 10.154

8.  A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.

Authors:  Seyedeh-Robab Elhami; Kazem Mohammad; Mohammad Ali Sahraian; Hassan Eftekhar
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

9.  Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

Authors:  O Kantarci; A Siva; M Eraksoy; R Karabudak; N Sütlaş; J Ağaoğlu; F Turan; M Ozmenoğlu; E Toğrul; M Demirkiran
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  Natural history of multiple sclerosis in a population-based cohort.

Authors:  M Debouverie; S Pittion-Vouyovitch; S Louis; F Guillemin
Journal:  Eur J Neurol       Date:  2008-07-15       Impact factor: 6.089

View more
  2 in total

1.  Reliability and Validity of the Turkish Version of the Multiple Sclerosis Knowledge Questionnaire.

Authors:  Ece Çinar; Yeşim Akkoç; Funda Çaliş; Musa Baklaci; Özgül Ekmekçi; Nur Yüceyar
Journal:  Noro Psikiyatr Ars       Date:  2022-02-23       Impact factor: 1.066

2.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.